Research graph
References from Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics
2011 · External reference
Major causes of death among men and women in China
10.1056/nejmsa050467 · 2005 · External reference
Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge
10.1002/hep.24569 · 2011 · External reference
Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients
10.1016/j.ejso.2006.11.015 · 2007 · External reference
A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy
10.1002/cncr.21461 · 2005 · External reference
The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer
10.1159/000127412 · 2007 · External reference
Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer
10.1002/jso.21986 · 2011 · External reference
Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
10.1007/s00262-012-1347-9 · 2013 · External reference
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma
10.1016/j.ejca.2011.09.001 · 2012 · External reference
Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
10.1038/bjc.2013.28 · 2013 · External reference
Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients
10.1245/s10434-011-1814-0 · 2012 · External reference
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
10.1038/bjc.2011.100 · 2011 · External reference
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
10.1038/bjc.2013.332 · 2013 · External reference
Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
10.1038/bjc.2013.135 · 2013 · External reference
Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
10.1186/1471-2407-13-78 · 2013 · External reference
A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation
10.1371/journal.pone.0025295 · 2011 · External reference
Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma
10.1007/s00268-008-9552-6 · 2008 · External reference
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers
10.1097/tp.0b013e3182187cf0 · 2011 · External reference
Immunity, inflammation, and cancer
10.1016/j.cell.2010.01.025 · 2010 · External reference
Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms
10.1002/ijc.24409 · 2009 · External reference
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy
10.1158/1078-0432.ccr-10-2245 · 2010 · External reference
Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
10.1038/bjc.2012.354 · 2012 · External reference
Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome
10.1016/j.amjcard.2008.05.006 · 2008 · External reference
Potentiation of Inflammatory CXCL8 Signalling Sustains Cell Survival in PTEN-deficient Prostate Carcinoma
10.1016/j.eururo.2012.08.032 · 2013 · External reference
Morin regulates the expression of NF-κB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma
10.1016/j.cbi.2009.02.004 · 2009 · External reference
Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells
10.1053/j.gastro.2013.01.046 · 2013 · External reference
Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma
10.1097/sla.0b013e3181a77e59 · 2009 · External reference
Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
10.1016/j.jhep.2010.08.041 · 2011 · External reference
Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer
10.1007/s00384-010-1052-0 · 2010 · External reference
Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
10.1016/j.jhep.2009.07.013 · 2010 · External reference
A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System
10.1016/j.jhep.2010.01.038 · 2010 · External reference
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
10.1136/gut.2003.035055 · 2005 · External reference
Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution
10.1245/s10434-012-2260-3 · 2012 · External reference
Predictors and patterns of recurrence after resection of hepatocellular carcinoma
10.1016/j.jamcollsurg.2003.07.003 · 2003 · External reference
Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China
10.1245/s10434-012-2269-7 · 2012 · External reference
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
10.1111/j.1365-2036.2011.04823.x · 2011 · External reference
Advanced hepatocellular carcinoma: which staging systems best predict prognosis?
10.1200/jco.2009.25.9895 · 2010 · External reference
HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer
10.1371/journal.pone.0026323 · 2011 · External reference
Resection and liver transplantation for hepatocellular carcinoma
10.1055/s-2005-871198 · 2005 · External reference
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
10.1056/nejmoa0804525 · 2008 · External reference
Predictors of survival after resection of early hepatocellular carcinoma
10.1097/sla.0b013e3181a38eb5 · 2009 · External reference
Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study
10.1245/s10434-010-1321-8 · 2011 · External reference
Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence
10.1097/01.sla.0000059988.22416.f2 · 2003 · External reference
Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma
10.1245/aso.2006.08.007 · 2006 · External reference
Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma
10.1038/sj.bjc.6605689 · 2010 · External reference
